FDA Panel Backs First-Of-A-Kind COVID-19 Pill From Merck
An FDA advisory panel has backed Merck's experimental antiviral medication to treat COVID.
LEARN MOREFDA Authorizes Pfizer's COVID-19 Treatment Pill
The drug is authorized for adults and children ages 12 and older who test positive, show early symptoms and face a high risk of hospitalization.
FDA Authorizes Pfizer's COVID-19 Treatment Pill
Pfizer via AP
December 22, 2021
U.S. health regulators on Wednesday authorized the first pill against COVID-19, a Pfizer drug that Americans will be able to take at home to head off the worst effects of the virus.
The drug, Paxlovid, is a faster, cheaper way to treat early COVID-19 infections, though initial supplies will be extremely limited. All of the previously authorized drugs against the disease require an IV or an injection.
An antiviral pill from Merck also is expected to soon win authorization. But Pfizer's drug is all but certain to be the preferred option because of its mild side effects and superior effectiveness, including a nearly 90% reduction in hospitalizations and deaths among patients most likely to get severe disease.
The Food and Drug Administration authorized Pfizer's drug for adults and children ages 12 and older with a positive COVID-19 test and early symptoms who face the highest risks of hospitalization. That includes older people and those with conditions like obesity and heart disease. Children eligible for the drug must weigh at least 88 pounds.
Pfizer currently has 180,000 treatment courses available worldwide, with roughly 60,000 to 70,000 allocated to the U.S. Federal health officials are expected to ration early shipments to the hardest hit parts of the country. Pfizer said the small supply is due to the manufacturing time — currently about nine months. The company says it can halve production time next year.
The U.S. government has agreed to purchase enough Paxlovid to treat 10 million people. Pfizer says it's on track to produce 80 million courses globally next year, under contracts with the U.K., Australia and other nations.
Additional reporting by The Associated Press.
5:26
How you can clean the air to protect yourself from COVID
People can remove harmful aerosol particles, like the virus that causes COVID, from the air on their own terms.
2:19
Moderna defends vax price hike, despite billions in taxpayer funding
The company is planning to raise the price of its COVID-19 vaccine from about $26 per dose up to $130 per dose.
9:14
What living with long COVID is really like
Scripps News talked to a dozen people with long-term COVID symptoms about their current experience and their hope for the future.
Top Stories
Blinken subpoenaed by top republican in Afghanistan withdrawal probe
A GOP chair of the House Foreign Affairs Committee has delivered a subpoena to the U.S. State Department for documents on the Afghanistan withdrawal.
6:29
ATF handcuffed by archaic records system
In 1986, Congress passed a ban on the ATF ever having a so-called federal gun registry or any kind of electronic database of firearms.
1:47
Why do screens affect our sleep?
58% of Americans say they look at a screen within an hour of bedtime.
